Clearance of Cryptococcus neoformans from immunologically suppressed mice
- PMID: 2499541
- PMCID: PMC313825
- DOI: 10.1128/iai.57.7.1946-1952.1989
Clearance of Cryptococcus neoformans from immunologically suppressed mice
Abstract
To assess the effects of cryptococcal antigen-induced immunosuppression on a Cryptococcus neoformans infection, CBA/J mice were injected intravenously with saline or suppressive doses of cryptococcal antigen (CneF) at weekly intervals and were then infected with viable C. neoformans cells. By the second week after infection, the cryptococcal antigen-injected mice had suppressed anticryptococcal delayed-type hypersensitivity (DTH) responses compared with the responses of the saline-treated, infected control mice. In addition, the immunosuppressed mice had higher numbers of cryptococcal CFU cultured from their lungs, livers, spleens, lymph nodes, and brains than did the control animals. A direct correlation of suppression of the anticryptococcal DTH response and reduced clearance of cryptococci from tissues was also observed after mice were given a single intravenous injection of CneF and infected. To determine whether or not the cryptococcal antigen was specifically reducing the clearance of C. neoformans or had a more generalized effect, mice were injected with saline or suppressive doses of CneF, infected with Listeria monocytogenes, and then followed daily for 7 days for the clearance of L. monocytogenes from spleens and on day 7 for DTH reactivity to Listeria antigen. There were no differences between the saline- and CneF-treated mice with respect to anti-Listeria DTH responses or clearance of L. monocytogenes from spleens, indicating that CneF was not altering natural resistance mechanisms responsible for early clearance of L. monocytogenes, nor was the CneF influencing the induction of the acquired immune response which was responsible for the late clearance of the bacteria. Together, these data indicate that the specific suppression of this cell-mediated immune response induced by cryptococcal antigen reduces the ability of the animals to eliminate the homologous organism (C. neoformans) but not a heterologous infectious agent, such as L. monocytogenes.
Similar articles
-
Liposomes, a potential immunoadjuvant and carrier for a cryptococcal vaccine.J Pharm Sci. 1998 Sep;87(9):1144-8. doi: 10.1021/js9704184. J Pharm Sci. 1998. PMID: 9724568
-
MIP-1 alpha contributes to the anticryptococcal delayed-type hypersensitivity reaction and protection against Cryptococcus neoformans.J Leukoc Biol. 1997 Feb;61(2):147-55. doi: 10.1002/jlb.61.2.147. J Leukoc Biol. 1997. PMID: 9021919
-
Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response.Infect Immun. 1993 Jul;61(7):2854-65. doi: 10.1128/iai.61.7.2854-2865.1993. Infect Immun. 1993. PMID: 8514388 Free PMC article.
-
Effects of immunization with Cryptococcus neoformans cells or cryptococcal culture filtrate antigen on direct anticryptococcal activities of murine T lymphocytes.Infect Immun. 1995 May;63(5):1645-51. doi: 10.1128/iai.63.5.1645-1651.1995. Infect Immun. 1995. PMID: 7729868 Free PMC article.
-
Polysaccharide antigens of the capsule of Cryptococcus neoformans.Infect Immun. 1994 May;62(5):1507-12. doi: 10.1128/iai.62.5.1507-1512.1994. Infect Immun. 1994. PMID: 8168912 Free PMC article. Review.
Cited by
-
Characterization of a cell population which amplifies the anticryptococcal delayed-type hypersensitivity response.Infect Immun. 1990 Feb;58(2):393-8. doi: 10.1128/iai.58.2.393-398.1990. Infect Immun. 1990. PMID: 2105273 Free PMC article.
-
Presentation of cryptococcal capsular polysaccharide (GXM) on activated antigen-presenting cells inhibits the T-suppressor response and enhances delayed-type hypersensitivity and survival.Immunology. 1997 Nov;92(3):334-9. doi: 10.1046/j.1365-2567.1997.00357.x. Immunology. 1997. PMID: 9486105 Free PMC article.
-
Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation.Infect Immun. 1995 Mar;63(3):770-8. doi: 10.1128/iai.63.3.770-778.1995. Infect Immun. 1995. PMID: 7868246 Free PMC article.
-
Idiopathic CD4+ T-lymphocytopenia in two patients.CMAJ. 1993 Dec 1;149(11):1679-83. CMAJ. 1993. PMID: 8242507 Free PMC article. No abstract available.
-
Cryptococcal meningitis: description of 3 cases and estimation of T-cell subsets.Indian J Pediatr. 2014 Jun;81(6):536-40. doi: 10.1007/s12098-013-1087-7. Epub 2013 Jun 18. Indian J Pediatr. 2014. PMID: 23775204
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources